Real-world evaluation of frst?line treatment of extensive stage small cell lung cancer with atezolizumab plus platinum/etoposide: a focus on patients with brain metastasis. Hanxiao Chen#,Xiangjuan Ma#,Jie Liu#, Yu Yang#, Yanhui He#,Yong Fang, Liping Wang, Jian Fang* · Jun Zhao*,Minglei Zhuo*,Clinical and Translational Oncology,

Molecular features of gastroenteropancreatic neuroendocrine carcinoma: A comparative analysis with lung neuroendocrine carcinoma and digestive adenocarcinomas. Jianwei Zhang*, Hanxiao Chen*,Junli Zhang, Sha Wang, Yanfang Guan, Wenguang Gu, Jie Li,Xiaotian Zhang, Jian Li, Xicheng Wang, hihao Lu, Jun Zhou, Zhi Peng, Yu Sun, Yang Shao,Lin Shen*, Minglei Zhuo*, Ming Lu*,Chin J Cancer Res,2024;36(1):90-102

Molecular subtypes, predictive markers and prognosis in small-cell lung carcinoma. Yanli Zhu,1 Sheng Li,2 Haiyue Wang,1 Wenhao Ren,1 Kaiwen Chi ,1 Jianghua Wu ,1 Luning Mao,1 Xiaozheng Huang,1 Minglei Zhuo,* Dongmei Lin*,Journal of Clinical Pathology,

Molecular subtype expression and genomic profiling differ between surgically resected pure and combined small cell lung carcinoma*,**Yanli Zhu a, Sheng Li b, , Haiyue Wang a,Kaiwen Chi a , Wenhao Ren a, Xiaozheng Huang a,Minglei Zhuo b*, Dongmei Lin *,Human Pathology,(2023) 141, 118e129

Clinical outcomes of atezolizumab in combination with etoposide/platinum for treatment of extensive-stage small-cell lung cancer: A real-world, multicenter, retrospective, controlled study in China. Hanxiao Chen1#, Xiangjuan Ma#, Jie Liu# , Yu Yang#, Yong Fang, Liping Wang, Jian Fang*, Jun Zhao*,Minglei Zhuo*,Chin J Cancer Res,s 2022;34(4):353-364

Zhuo M, Guan Y, Yang X, Hong L, Wang Y, Li Z, Chen R, Abbas HA, Chang L, Gong Y, Wu N, Zhong J, Chen W, Chen H, Dong Z, Zhu X, Li J, Wang Y, An T, Wu M, Wang Z, Wang J, Roarty EB, Rinsurongkawong W, Lewis J, Roth JA, Swisher SG, Lee JJ, Heymach JV, Wistuba II, Kalhor N, Yang L, Yi X, Futreal PA, Glisson BS, Xia X, Zhang J, Zhao J. The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma. doi: 10.1158/1078-0432.CCR-19-0556. Epub 2019 Nov 6. PMID: 31694833; PMCID: PMC7024651.,Clin Cancer Res.,2020 Feb 15;26(4):892-901.

Yida Wang1,2#, Hanxiao Chen3#, Tianzhuo Zhang1, Xue Yang3, Jia Zhong3, Yuyan Wang3, Yujia Chi3, Meina Wu3, Tongtong An3, Jianjie Li3, Xinghui Zhao3, Zhi Dong3, Ziping Wang3, Jun Zhao*, Minglei Zhuo*, Jing Huang*,Ann Transl Med,Ann Transl Med 2021;9(1):33

Xiang Li , Shi Yan, Jichun Yang, Yaqi Wang, Chao Lv, Shaolei Li , Jun Zhao, Yue Yang, Minglei Zhuo* and Nan Wu*,Frontiers oncology,2021（10）2957

Analysis of MET kinase domain rearrangement in NSCLC Minglei Zhuoa,1, Zhen Liangb,1, Yuting Yid,1, Nan Wuc, Xue Yanga, Jia Zhonga, Xiaohan Chena, Yi Huange, Zicheng Yue, Chang Liud, Xiaoling Zengd, Wenguang Gud, Jun Zhaoa,*,LUNG CANCER,145 (2020) 140–143

Characterization of Microbiota in Cancerous Lung and the Contralateral Non-Cancerous Lung Within Lung Cancer Patients Minglei Zhuo1?, Tongtong An1?, Chaoting Zhang2* and Ziping Wang1*,frontiers oncology,2020:10:1584.

Zhao J, Lin G, Zhuo M, Fan Z, Miao L, Chen L, Zeng A, Yin R, Ou Y, Shi Z, Yin J, Gao W, Chen J, Zhou X, Zeng Y, Liu X, Xu H, Chen R, Xia X, Carbone DP. Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib.,LUNG CANCER,2020:141:114-118.

The adverse events associated with combination immunotherapy in cancers: Challenges and chances,Asia-Pac J Clin Oncol. 2020;1–6.,16(5):e154-e159

老年肺癌综合治疗学, 参编, 北京大学医学出版社, 2020.11

优秀援疆干部人才, 优秀援疆干部人才, 第1完成人, 新疆维吾尔自治区党委, 2020.1

肺癌内科药物治疗，包括分子靶向及免疫治疗疗效预测、耐药机制研究

肺大细胞神经内分泌癌的分子图谱构建及其驱动基因的 功能鉴定, 课题负责人, 2022.1.1～2024.12.31, 国自然

非小细胞肺癌外周血免疫指标检测对于纳武单抗疗效和不良反应的预测价值分析, 课题负责人, 2020.1.1～2021.12.31, 北京大学肿瘤医院

基于转录组的分子分型新技术在小细胞肺癌免疫治疗中 的应用和预测价值分析, 课题负责人, 2022.1.1～2024.12.31, 首发课题

安罗替尼对肺癌免疫微环境和外周血免疫状态的影响及其分子机制, 课题负责人, 2020.1.1～2022.12.31, 北京市医管局